Long-term outcomes in patients with pulmonary embolism: results from a longitudinal cohort study.
Patients with pulmonary embolism (PE) have increased mortality in short-term, however long-term prognosis is not well-defined. In this long-term cohort study, we aimed to determine if PE was associated with increased risk of mortality or serious clinical events (SCE). Secondary aims were to ascertain predictors of mortality and SCE. Patients admitted with clinical suspicion of PE were prospectively recruited from July-2002 to May-2003 and followed-up till March-2015. Clinical outcomes in patients with PE were compared to those without PE. SCE was defined as composite of mortality, malignancy, cardiovascular events, recurrent venous thromboembolism and chronic thromboembolic pulmonary hypertension. A total of 501 patients with median follow-up of 11.9 years (IQR 3.91-12.28) were included. PE was diagnosed in 104 (20.7%) patients. Overall, 45.9% died and 57.1% developed SCE during follow-up, with no significant difference in PE and no-PE groups (both p >0.5). Major determinants of mortality were age (HR 1.06 per-year, 95%CI 1.05-1.08), malignancy (HR 2.19, 95%CI 1.64-2.91) and congestive heart failure (CHF) (HR 1.72, 95%CI 1.23-2.42). Factors associated with increased risk of SCE were age (HR 1.05 per-year, 95%CI 1.04-1.06), malignancy (HR1.93, 95%CI 1.48-2.52) and CHF (HR 1.77, 95%CI 1.29-2.43). In patients without PE, elevated D-dimer concentration was not found to be associated with diagnosis of malignancy during follow-up (HR 1.31, 95%CI 0.55-3.12). In this prospective study, we did not find association between PE and risk of all-cause mortality or SCE. Major determinants of poor clinical outcomes were advancing age and underlying comorbidities. This article is protected by copyright. All rights reserved.